Question 1

What are the specific benefits of participating in this trial for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available to me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination of treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer does not respond to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or travel considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer clinical trial (NCT07040228). Contact the study team or your healthcare provider for specific answers.

What this study is about